|
1
|
Johnson DE, Burtness B, Leemans CR, Lui
VWY, Bauman JE and Grandis JR: Head and neck squamous cell
carcinoma. Nat Rev Dis Primers. 6:922020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Solomon B, Young RJ and Rischin D: Head
and neck squamous cell carcinoma: Genomics and emerging biomarkers
for immunomodulatory cancer treatments. Semin Cancer Biol.
52:228–240. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kitamura N, Sento S, Yoshizawa Y, Sasabe
E, Kudo Y and Yamamoto T: Current trends and future prospects of
molecular targeted therapy in head and neck squamous cell
carcinoma. Int J Mol Sci. 22:2402020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Panarese I, Aquino G, Ronchi A, Longo F,
Montella M, Cozzolino I, Roccuzzo G, Colella G, Caraglia M and
Franco R: Oral and oropharyngeal squamous cell carcinoma:
Prognostic and predictive parameters in the etiopathogenetic route.
Expert Rev Anticancer Ther. 19:105–119. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hanoteau A, Newton JM, Krupar R, Huang C,
Liu HC, Gaspero A, Gartrell RD, Saenger YM, Hart TD, Santegoets SJ,
et al: Tumor microenvironment modulation enhances immunologic
benefit of chemoradiotherapy. J Immunother Cancer. 7:102019.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Göttgens EL, Ostheimer C, Span PN, Bussink
J and Hammond EM: HPV, hypoxia and radiation response in head and
neck cancer. Br J Radiol. 92:201800472019.PubMed/NCBI
|
|
7
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta
R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS,
et al: Ferroptosis: An iron-dependent form of nonapoptotic cell
death. Cell. 149:1060–1072. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang C, Liu X, Jin S, Chen Y and Guo R:
Ferroptosis in cancer therapy: A novel approach to reversing drug
resistance. Mol Cancer. 21:472022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao L, Zhou X, Xie F and Zhang L, Yan H,
Huang J, Zhang C, Zhou F, Chen J and Zhang L: Ferroptosis in cancer
and cancer immunotherapy. Cancer Commun (Lond). 42:88–116. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu L, Li YY, Zhang YC, Wu YX, Guo DD, Long
D and Liu ZH: A novel ferroptosis-related gene signature to predict
prognosis in patients with head and neck squamous cell carcinoma.
Dis Markers. 2021:57599272021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lu T, Zhang Z, Pan X, Zhang J, Wang X,
Wang M, Li H, Yan M and Chen W: Caveolin-1 promotes cancer
progression via inhibiting ferroptosis in head and neck squamous
cell carcinoma. J Oral Pathol Med. 51:52–62. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yau TY, Sander W, Eidson C and Courey AJ:
SUMO interacting motifs: Structure and function. Cells.
10:28252021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao X: SUMO-mediated regulation of
nuclear functions and signaling processes. Mol Cell. 71:409–418.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li H, Chen L, Li Y and Hou W:
SUMO-specific protease 1 inhibitors-A literature and patent
overview. Expert Opin Ther Pat. 32:1207–1216. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gao Y, Wang R, Liu J, Zhao K, Qian X, He X
and Hong L: SENP1 promotes triple-negative breast cancer invasion
and metastasis via enhancing CSN5 transcription mediated by GATA1
deSUMOylation. Int J Biol Sci. 18:2186–2201. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dong B, Gao Y, Kang X, Gao H, Zhang J, Guo
H, You MJ, Xue W, Cheng J and Huang Y: SENP1 promotes proliferation
of clear cell renal cell carcinoma through activation of
glycolysis. Oncotarget. 7:80435–80449. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun W, Liu X, Yang X, Jing X, Duan C, Yang
G, Wu C, Huang H, Luo Q, Xia S, et al: SENP1 regulates the
transformation of lung resident mesenchymal stem cells and is
associated with idiopathic pulmonary fibrosis progression. Cell
Commun Signal. 20:1042022. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bai YT, Xiao FJ, Wang H, Ge RL and Wang
LS: Hypoxia protects H9c2 cells against ferroptosis through
SENP1-mediated protein DeSUMOylation. Int J Med Sci. 18:1618–1627.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kuwata H and Hara S: Role of acyl-CoA
synthetase ACSL4 in arachidonic acid metabolism. Prostaglandins
Other Lipid Mediat. 144:1063632019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Doll S, Proneth B, Tyurina YY, Panzilius
E, Kobayashi S, Ingold I, Irmler M, Beckers J, Aichler M, Walch A,
et al: ACSL4 dictates ferroptosis sensitivity by shaping cellular
lipid composition. Nat Chem Biol. 13:91–98. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen X, Li J, Kang R, Klionsky DJ and Tang
D: Ferroptosis: Machinery and regulation. Autophagy. 17:2054–2081.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Quan J, Bode AM and Luo X: ACSL family:
The regulatory mechanisms and therapeutic implications in cancer.
Eur J Pharmacol. 909:1743972021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Blum A, Wang P and Zenklusen JC: SnapShot:
TCGA-analyzed tumors. Cell. 173:5302018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Onofri A, Terzaroli N and Russi L: Linear
models for diallel crosses: A review with R functions. Theor Appl
Genet. 134:585–601. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
He F, Chen Z, Deng W, Zhan T, Huang X,
Zheng Y and Yang H: Development and validation of a novel
ferroptosis-related gene signature for predicting prognosis and
immune microenvironment in head and neck squamous cell carcinoma.
Int Immunopharmacol. 98:1077892021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang W, Zhang J, Wang Y, Xu Y and Zhang S:
Identifies microtubule-binding protein CSPP1 as a novel
cancer biomarker associated with ferroptosis and tumor
microenvironment. Comput Struct Biotechnol J. 20:3322–3335. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhu T, Shi L, Yu C, Dong Y, Qiu F, Shen L,
Qian Q, Zhou G and Zhu X: Ferroptosis promotes photodynamic
therapy: Supramolecular photosensitizer-inducer nanodrug for
enhanced cancer treatment. Theranostics. 9:3293–3307. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Han ZJ, Feng YH, Gu BH, Li YM and Chen H:
The post-translational modification, SUMOylation, and cancer
(Review). Int J Oncol. 52:1081–1094. 2018.PubMed/NCBI
|
|
30
|
Wang X, Liang X, Liang H and Wang B:
SENP1/HIF-1α feedback loop modulates hypoxia-induced cell
proliferation, invasion, and EMT in human osteosarcoma cells. J
Cell Biochem. 119:1819–1826. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hao L, Dong Y, Zhang JJ, He HG, Chen JG,
Zhang SQ, Zhang QJ, Wu W, Han CH and Shi ZD: Melatonin decreases
androgen-sensitive prostate cancer growth by suppressing SENP1
expression. Transl Androl Urol. 11:91–103. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shen X, Ni R, Qian X, Yu C, Wu H, Ni J,
Zhu W and Gao X: A verification study on the genes associated with
laryngeal squamous cell carcinoma by cDNA microarray. Lin Chuang Er
Bi Yan Hou Tou Jing Wai Ke Za Zhi. 24:411–413. 2010.(In Chinese).
PubMed/NCBI
|
|
33
|
Gao C, Xiao F, Zhang L, Sun Y and Wang L,
Liu X, Sun H, Xie Z, Liang Y, Xu Q and Wang L: SENP1
inhibition suppresses the growth of lung cancer cells through
activation of A20-mediated ferroptosis. Ann Transl Med.
10:2242022. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Vertegaal ACO: Signalling mechanisms and
cellular functions of SUMO. Nat Rev Mol Cell Biol. 23:715–731.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mevissen TET and Komander D: Mechanisms of
deubiquitinase specificity and regulation. Annu Rev Biochem.
86:159–192. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kukkula A, Ojala VK, Mendez LM, Sistonen
L, Elenius K and Sundvall M: Therapeutic potential of targeting the
SUMO pathway in cancer. Cancers (Basel). 13:44022021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bawa-Khalfe T, Yang FM, Ritho J, Lin HK,
Cheng J and Yeh ET: SENP1 regulates PTEN stability to dictate
prostate cancer development. Oncotarget. 8:17651–17664. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sun XX, Chen Y, Su Y, Wang X, Chauhan KM,
Liang J, Daniel CJ, Sears RC and Dai MS: SUMO protease SENP1
deSUMOylates and stabilizes c-Myc. Proc Natl Acad Sci USA.
115:10983–10988. 2018. View Article : Google Scholar : PubMed/NCBI
|
